A citation-based method for searching scientific literature

Sofia Esteves, Sara Duarte-Silva, PatrĂ­cia Maciel. Med Res Rev 2017
Times Cited: 12

Henry L Paulson, Vikram G Shakkottai, H Brent Clark, Harry T Orr. Nat Rev Neurosci 2017
Times Cited: 136

List of shared articles

Times cited

Polyglutamine spinocerebellar ataxias: emerging therapeutic targets.
Andreia Neves-Carvalho, Sara Duarte-Silva, Andreia Teixeira-Castro, PatrĂ­cia Maciel. Expert Opin Ther Targets 2020

Universal RNAi Triggers for the Specific Inhibition of Mutant Huntingtin, Atrophin-1, Ataxin-3, and Ataxin-7 Expression.
Anna Kotowska-Zimmer, Yuliya Ostrovska, Marta Olejniczak. Mol Ther Nucleic Acids 2020

CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells.
Lang He, Shang Wang, Linliu Peng, Huifang Zhao, Shuai Li, Xiaobo Han, Jean de Dieu Habimana, Zhao Chen, Chunrong Wang, Yun Peng,[...]. Transl Psychiatry 2021

Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 Nickases.
Magdalena Dabrowska, Wojciech Juzwa, Wlodzimierz J Krzyzosiak, Marta Olejniczak. Front Neurosci 2018

Cerebellar lncRNA Expression Profile Analysis of SCA3/MJD Mice.
Zhe Long, Tianjiao Li, Zhao Chen, Yun Peng, Chunrong Wang, Xiaocan Hou, Hongyu Yuan, Puzhi Wang, Yue Xie, Lang He,[...]. Int J Genomics 2018

Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases.
Amanda K Davis, William B Pratt, Andrew P Lieberman, Yoichi Osawa. Cell Mol Life Sci 2020